相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates
Shin-ichi Yokota et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
In vivo efficacy of sitafloxacin in a new murine model of non-typeable Haemophilus influenzae pneumonia by sterile intratracheal tube
Shigeki Nakamura et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
The changing epidemiology of resistance
Peter M. Hawkey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis
Timothy E Albertson et al.
Expert Review of Respiratory Medicine (2009)
Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV:: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae
Ryo Okumura et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Sitafloxacin hydrate for bacterial infections
David Leif Anderson
DRUGS OF TODAY (2008)
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci
Seong Geun Hong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV
Masato Touyama et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus
N Yamamoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model
Y Fukuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Quantitative assessment of the hepatic pharmacokinetics of the antimicrobial sitafloxacin in humans using in vivo 19F magnetic resonance spectroscopy
GS Payne et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity
RS Dawe et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae:: data from the global PROTEKT surveillance programme
R Canton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan
S Yokota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A critical review of the fluoroquinolones - Focus on respiratory tract infections
GG Zhanel et al.
DRUGS (2002)
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects
J O'Grady et al.
XENOBIOTICA (2001)
The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens
A MacGowan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
